- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x 3OR: 3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-5-[(3-oxo-1,2-oxazinan-2-yl)methyl]benzamide(Non-covalent)
3OR.3: 22 residues within 4Å:- Chain A: G.19, G.20, K.37, I.39, L.55, L.58, V.67, I.81, M.83, H.128, R.129, D.130, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159, N.161
- Ligands: ANP.1
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.58, A:I.81, A:R.129, A:L.155, A:N.161
- Hydrogen bonds: A:K.37, A:D.148
- pi-Stacking: A:F.149
- Halogen bonds: A:V.67, A:S.152
3OR.13: 22 residues within 4Å:- Chain B: G.19, G.20, K.37, I.39, L.55, L.58, V.67, I.81, M.83, H.128, R.129, D.130, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159, N.161
- Ligands: ANP.11
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:L.58, B:I.81, B:R.129, B:L.155, B:N.161
- Hydrogen bonds: B:K.37
- pi-Stacking: B:F.149
- Halogen bonds: B:V.67, B:S.152
- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
PGE.4: 10 residues within 4Å:- Chain A: I.126, R.129, G.150, V.151, G.153, I.156
- Chain B: G.153, Q.154, D.157
- Ligands: PGE.14
1 PLIP interactions:1 interactions with chain A- Water bridges: A:M.127
PGE.14: 10 residues within 4Å:- Chain A: G.153, Q.154, D.157
- Chain B: I.126, R.129, G.150, V.151, G.153, I.156
- Ligands: PGE.4
1 PLIP interactions:1 interactions with chain B- Water bridges: B:M.127
- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: N.18, G.165, T.166, R.167
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.18, A:T.166, A:R.167, A:R.167
- Water bridges: A:T.166
- Salt bridges: A:R.167
SO4.6: 5 residues within 4Å:- Chain A: H.40, L.41, E.42
- Chain B: T.178, H.179
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:E.42, B:H.179
- Salt bridges: B:H.179
SO4.7: 4 residues within 4Å:- Chain A: R.121, S.181, V.182
- Chain B: K.44
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Water bridges: B:K.44, B:K.44
- Salt bridges: B:K.44, A:R.121
- Hydrogen bonds: A:V.182
SO4.8: 6 residues within 4Å:- Chain A: R.141, G.142, V.277, D.278, F.279, A.280
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:F.279, A:A.280
- Water bridges: A:G.142
SO4.9: 4 residues within 4Å:- Chain A: S.239, L.240, E.241, R.271
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.240, A:E.241
- Salt bridges: A:R.271
SO4.10: 2 residues within 4Å:- Chain A: E.9, K.10
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.10
- Salt bridges: A:K.10
SO4.15: 4 residues within 4Å:- Chain B: N.18, G.165, T.166, R.167
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.18, B:T.166, B:R.167, B:R.167
- Salt bridges: B:R.167
SO4.16: 5 residues within 4Å:- Chain A: T.178, H.179
- Chain B: H.40, L.41, E.42
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:E.42, A:H.179
- Salt bridges: A:H.179
SO4.17: 4 residues within 4Å:- Chain A: K.44
- Chain B: R.121, S.181, V.182
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:V.182
- Salt bridges: B:R.121, A:K.44
- Water bridges: A:K.44, A:K.44
SO4.18: 6 residues within 4Å:- Chain B: R.141, G.142, V.277, D.278, F.279, A.280
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:F.279, B:A.280
- Water bridges: B:G.142
SO4.19: 4 residues within 4Å:- Chain B: S.239, L.240, E.241, R.271
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.240, B:E.241
- Salt bridges: B:R.271
SO4.20: 2 residues within 4Å:- Chain B: E.9, K.10
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.10
- Salt bridges: B:K.10
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Isshiki, Y. et al., Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2011-03-02
- Peptides
- Dual specificity mitogen-activated protein kinase kinase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x 3OR: 3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-5-[(3-oxo-1,2-oxazinan-2-yl)methyl]benzamide(Non-covalent)
- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Isshiki, Y. et al., Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2011-03-02
- Peptides
- Dual specificity mitogen-activated protein kinase kinase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A